Medscape3d
Memantine: A Treatment for Alzheimer's Disease With a New Formulation
The recommended target dose is 10 mg twice daily. The US FDA recently approved an extended-release (ER) formulation of memantine for once-daily 28-mg dosing. Memantine ER was evaluated in a 24 ...
Monthly Prescribing Reference11y
Namenda Xr
Memantine HCl 7mg, 14mg, 21mg, 28mg; ext-rel caps. Tabs—60; Titration Pak (28 x 5mg + 21 x 10mg)—1; Oral soln—contact supplier; XR caps 7mg, 21mg—30; 14mg, 28mg—30, 90; XR Titration Pak ...
Business Wire1mon
Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin
has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which references Abbvie’s NAMZARIC ®, and Everolimus 2 mg, 3 mg and 5 mg extended-release capsules, which ...
Nature2mon
Memantine and gabapentin are useful in the treatment of congenital nystagmus
Nystagmus is characterized by involuntary to and fro movement of the eyes. There is evidence to indicate that memantine and gabapentin can reduce acquired nystagmus, but these drugs have not been ...
Medscape5d
Memantine: A Treatment for Alzheimer's Disease With a New Formulation
Data taken from [67–70]. A new extended-release formulation of memantine, which provides up to 28 mg once-daily dose, was recently approved by the US FDA. Memantine is a moderate-affinity ...